首页 > 市场调查报告书 > 医疗设备

医学影像诊断生技设备

美国萤光原位杂交成像系统市场规模和预测、区域份额、趋势和成长机会分析报告范围：按产品、应用和最终用户

市场调查报告书

商品编码

1372560

美国萤光原位杂交成像系统市场规模和预测、区域份额、趋势和成长机会分析报告范围：按产品、应用和最终用户

US Fluorescence In-Situ Hybridization Imaging Systems Market Size and Forecasts, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, and End User

出版日期: 2023年10月03日 | 出版商:

The Insight Partners | 英文 82 Pages | 订单完成后即时交付

价格

简介目录图表

美国萤光原位杂交 (FISH) 成像系统市场预计将从 2022 年的 4.19 亿美元增至 2030 年的 7.33 亿美元。预计 2022 年至 2030 年该市场将以 7.3% 的复合年增长率成长。

推动市场成长的关键因素是目标疾病盛行率的上升以及体外诊断研发投资的增加。然而，鱼类成像系统和程序的高成本在一定程度上阻碍了市场的成长。

萤光原位杂交（FISH）成像系统市场的市场机会

由于技术进步的激增，FISH 成像系统正在经历显着的发展，从而带来改变基因研究和诊断格局的尖端创新。这些进步包括增强的光学、更灵敏和多功能的萤光团以及复杂的自动化功能。现代 FISH 成像系统整合了这些升级功能，可提供更高的灵敏度、更高的影像解析度和更快的处理时间。此外，这些技术进步将FISH成像的应用范围从癌症诊断扩展到遗传倾向检测。 2021 年 7 月，BioView 和 Capio Biosciences 合作创建了一个从全血中收集循环肿瘤细胞 (CTC) 的平台。透过整合各自的技术，这些公司进一步致力于改进 CTC 液体活检下游分析。同样，BioView 和 Capio Biosciences 于 2020 年 12 月与 RUBYnanomed 合作，创建了一种独特的成像解决方案，以加速 CTC 技术在临床中的接受和采用，从而增强癌症检测。因此，FISH 成像系统的技术进步为萤光原位杂交 (FISH) 成像系统市场的公司创造了重大机会。

阻碍萤光原位杂交 (FISH) 成像系统市场的因素

电脑断层扫描 (CT) 扫描、免疫组织化学 (IHC)、骨骼扫描、FISH 影像、磁振造影 (MRI)、正子断层扫描 (PET) 扫描、超音波和 X 光是用于检测癌症的测试。 FISH 成像分析是癌症检测中不太常用的方法，因为其成本比其他方法相对较高。除了设备成本之外，与试剂、其他消耗品和专业人员任命相关的费用也会增加基于 FISH 成像的评估的总体成本。例如，在美国，透过 IHC 检测 ALK 基因非小细胞肺癌的每次检测费用为 90.07 美元，低于 FISH 和 IHC 的独立或平行检测（美国的费用约为 441.85 美元）。因此，程序和系统的高成本限制了萤光原位杂交（FISH）成像系统市场的成长。

萤光原位杂交 (FISH) 成像系统市场：细分概述

根据产品，萤光原位杂交 (FISH) 成像系统市场分为仪器、耗材、配件和软体。消耗品领域在 2022 年占据更大的市场份额，预计复合年增长率更高。耗材是萤光原位杂交 (FISH) 成像系统市场中最有前途的部分，将在未来几年带来巨大的成长。 FISH耗材包括杂交缓衝液、探针、标籤检测试剂盒、讯号放大检测试剂盒等。 Abbott、F. Abnova 和 Thermo Fisher Scientific 等製造商的存在增强了耗材领域的市场。此外，这些产品经常用于各种研究诊断过程，预计将推动消费。因此，提供探针和套件的各种市场参与者的存在以及市场参与者的技术进步可能会在未来几年推动该细分市场的市场。

根据应用，萤光原位杂交（FISH）影像系统市场分为癌症诊断、遗传疾病诊断、传染病诊断等。癌症诊断领域在 2022 年占据更大的市场份额，预计复合年增长率更高。 FISH 技术极大地有益于癌症诊断。 FISH 成像系统可以寻找基因变化并帮助检测异常。据英国癌症研究中心称，FISH 检测可用于诊断多种癌症，包括乳腺癌、淋巴瘤、肺癌、前列腺癌、慢性淋巴细胞白血病(CLL)、急性淋巴细胞白血病(ALL)、急性髓性白血病(AML )、慢性骨髓性白血病 (CML)、骨髓瘤、尤文氏肉瘤和黑色素瘤皮肤癌。

根据最终用户，萤光原位杂交 (FISH) 影像系统市场分为诊断实验室、合约研究组织、製药和生物技术公司等。诊断实验室细分市场到 2022 年将占据更大的市场份额，预计该细分市场的复合年增长率将更高。诊断实验室参与各种研究项目，开发用于萤光原位杂交 (FISH) 成像过程的多种技术和产品。研究和技术的空前发展为医疗保健和生命科学领域的转型创造了潜力。萤光原位杂交（FISH）影像系统的临床应用非常广泛，为提高慢性病的诊断和治疗能力提供了机会。它们在基因发现和罕见遗传疾病的诊断方面具有巨大的潜力。这些技术越来越多地用于分析影响癌症、高血压、糖尿病和肾臟疾病等常见疾病发展的罕见和常见遗传因素。

萤光原位杂交 (FISH) 影像系统市场：地理概况

分子遗传学和细胞遗传学领域对先进诊断工具的需求不断增长，以及遗传性疾病和癌症盛行率的上升，推动了萤光原位杂交 (FISH) 影像系统的采用。根据美国癌症协会2022年公布的资料，美国新诊断癌症病例约190万例，癌症死亡人数为609,360人。这些系统提供遗传物质的高解析度成像，使研究人员和临床医生能够更准确地检测染色体异常和基因突变。此外，对个人化医疗和标靶治疗的日益关注导致涉及遗传分析的研究活动激增，从而增加了对 FISH 成像系统的需求。这些系统直接提供细胞内基因序列详细空间资讯的能力已被证明在研究和临床应用中具有无价的价值。近年来，FISH 成像系统技术进步的普及程度也有所提高，例如自动化程度的提高、通量的提高以及影像分析软体的增强。因此，实验室和医疗机构能够更好地处理大量样本并有效产生精确的结果。因此，上述因素将推动美国萤光原位杂交（FISH）成像系统市场的成长。

在准备萤光原位杂交 (FISH) 影像系统市场报告时提到的一些主要主要和次要来源包括世界银行数据、国家卫生服务体系 (NHS)、FDA（食品和药物管理局）、EMA （欧洲药品管理局）和WHO（世界卫生组织）。

FISH imaging systems are witnessing a remarkable evolution due to the surge in technological advancements, which result in cutting-edge innovations transforming the landscape of genetic research and diagnostics. These advancements include enhanced optics, more sensitive and versatile fluorophores, and sophisticated automation features. Modern FISH imaging systems, integrated with these upgraded features, offer greater sensitivity, improved image resolution, and faster processing times. Moreover, these technological advancements have extended the application scope of FISH imaging from cancer diagnosis to genetic predisposition testing. In July 2021, BioView and Capio Biosciences collaborated to create a platform for collecting circulating tumor cells (CTCs) from whole blood. By integrating their technologies, these companies further worked on improving the CTC liquid biopsy downstream analysis. Similarly, in collaboration, BioView and Capio Biosciences partnered with RUBYnanomed in December 2020 to create a unique imaging solution to accelerate the acceptance and adoption of CTC technology in clinics to enhance cancer detection. Thus, technological advancements in FISH imaging systems create significant opportunities for companies in the fluorescence in-situ hybridization (FISH) imaging systems market.

Factors Hampering Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

Computerized tomography (CT) scan, immunohistochemistry (IHC), bone scan, FISH imaging, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, ultrasound, and X-ray are among the tests used to detect cancer. FISH imaging analysis is a less commonly used method in cancer detection because of its relatively higher cost than other methods. In addition to the equipment cost, the expenses associated with reagents, other consumables, and specialized personnel appointments can add to the overall cost of evaluation based on FISH imaging. For instance, the detection of ALK gene non-small cell lung cancer by IHC costs US$ 90.07 in the US for every test, which is less than either independent or parallel testing by FISH and IHC (costing ~US$ 441.85 in the US). Thus, the high cost of procedures and systems limits the growth of the fluorescence in situ hybridization (FISH) imaging systems market.

Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market: Segmental Overview

Based on product, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held a larger market share in 2022 and is anticipated to register a higher CAGR. Consumables are the most promising segment of the fluorescence in-situ hybridization (FISH) imaging system market that will contribute to tremendous growth in the coming years. FISH consumables include hybridization buffers, probes, tag detection kits, signal amplification detection kits, and others. The presence of manufacturers such as Abbott, F. Abnova, and Thermo Fisher Scientific bolsters the market for the consumables segment. Additionally, these products are frequently used in various research diagnosis processes, which is expected to propel consumption. Thus, the presence of various market players offering probes & kits and technological advancements by market players are likely to propel the market for the segment in the coming years.

Based on application, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnosis, and others. The cancer diagnosis segment held a larger market share in 2022 and is anticipated to register a higher CAGR. FISH technology has tremendously benefited cancer diagnosis. FISH imaging systems can look for gene changes and help detect anomalies. According to Cancer Research UK, FISH testing is used for the diagnosis of several cancers, including breast cancer, lymphoma, lung cancer, prostate cancer, chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myeloma, Ewings sarcoma, and melanoma skin cancer.

Based on end user, the fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organization, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held a larger market share in 2022 and same segment is anticipated to register a higher CAGR. The diagnostic laboratories are involved in various research projects to develop several technologies and products for fluorescence in-situ hybridization (FISH) imaging processes. Unprecedented developments in research and technologies have created the potential for transformation in the healthcare and life sciences sectors. The clinical applications of fluorescence in-situ hybridization (FISH) imaging systems are vast and offer opportunities to enhance diagnosis and treatment capabilities for chronic disease. They offer huge potential in gene discovery and diagnosis of rare genetic disorders. The technologies are increasingly used to analyze rare and common genetic factors influencing the development of common diseases, such as cancer, high blood pressure, diabetes, and renal diseases.

Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market: Geographical Overview

The growing demand for advanced diagnostic tools in molecular genetics and cytogenetics and the rising prevalence of genetic disorders and cancer fuel the adoption of fluorescence in-situ hybridization (FISH) imaging systems. As per data published by the American Cancer Society in 2022, there are around 1.9 million new cancer cases diagnosed in the US and 609,360 cancer deaths. These systems offer high-resolution imaging of genetic material, enabling researchers and clinicians to detect chromosomal abnormalities and gene mutations with greater accuracy. Furthermore, the increasing focus on personalized medicine and targeted therapies has led to an upsurge in research activities involving genetic analysis, bolstering the demand for FISH imaging systems. The ability of these systems to provide detailed spatial information on gene sequences directly within cells has proven invaluable in both research and clinical applications. The popularity of technological advancements in FISH imaging systems, such as improved automation, higher throughput, and enhanced image analysis software, has also increased in recent years. As a result, laboratories and medical institutions are better equipped to handle larger volumes of samples and generate precise results efficiently. Thus, the abovementioned factors will fuel the fluorescence in-situ hybridization (FISH) imaging systems market growth in the US.

A few of the major primary and secondary sources referred to while preparing the report on the fluorescence in-situ hybridization (FISH) imaging systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the fluorescence in-situ hybridization (FISH) imaging systems market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the US fluorescence in-situ hybridization (FISH) imaging systems market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth US market trends and outlook coupled with the factors driving the fluorescence in-situ hybridization (FISH) imaging systems market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 US PEST Analysis

5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Rising Prevalence of Target Disorders
- 5.1.2 Increasing R&D Investments in In-Vitro Diagnostics
5.2 Key Market Restraints:
- 5.2.1 High Cost of FISH Imaging Systems and Procedures
5.3 Key Market Opportunities:
- 5.3.1 Technological Advancements in Fluorescence in Situ Hybridization Imaging
5.4 Future Trends:
- 5.4.1 Automation and Digitalization of FISH Imaging Technique
5.5 Impact Analysis:

6. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - US Market Analysis

6.1 Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030

7. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Instruments
- 7.3.1 Overview
- 7.3.2 Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Consumables
- 7.4.1 Overview
- 7.4.2 Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Accessories
- 7.5.1 Overview
- 7.5.2 Accessories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Software
- 7.6.1 Overview
- 7.6.2 Software: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

8. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Cancer Diagnosis
- 8.3.1 Overview
- 8.3.2 Cancer Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Disease Diagnosis
- 8.4.1 Overview
- 8.4.2 Genetic Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Infectious Disease Diagnosis
- 8.5.1 Overview
- 8.5.2 Infectious Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

9. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization
- 9.4.1 Overview
- 9.4.2 Contract Research Organization: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical And Biotechnological Companies
- 9.5.1 Overview
- 9.5.2 Pharmaceutical and Biotechnological Companies: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

10. Fluorescence In-situ Hybridization (FISH) Imaging Systems Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Euroclone SpA
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 TissueGnostics GmbH
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Agilent Technologies Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Abnova Taiwan Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 BioGenex Laboratories Inc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Leica Biosystems Nussloch GmbH
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 MetaSystems Probes GmbH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Bio-View Ltd
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Thermo Fisher Scientific Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Applied Spectral Imaging
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 PerkinElmer Inc
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation
Table 2. Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Table 4. Recent Inorganic Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
Table 5. Recent Organic Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market
Table 6. Glossary of Terms, Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

List Of Figures

Figure 1. US PEST Analysis
Figure 2. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2020 - 2030
Figure 5. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Instruments: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Consumables: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Accessories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
Figure 11. Cancer Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infectious Disease Diagnosis: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. US Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16. Diagnostic Laboratories: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Contract Research Organization: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Pharmaceutical And Biotechnological Companies: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Growth Strategies in the Fluorescence In-situ Hybridization (FISH) Imaging Systems Market

02-2729-4219

+886-2-2729-4219

License/价格

美国萤光原位杂交成像系统市场规模和预测、区域份额、趋势和成长机会分析报告范围：按产品、应用和最终用户

US Fluorescence In-Situ Hybridization Imaging Systems Market Size and Forecasts, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, and End User

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：美国萤光原位杂交 (FISH) 影像系统市场格局

第 5 章：美国萤光原位杂交 (FISH) 影像系统市场 - 主要产业动态

第 6 章：萤光原位杂交 (FISH) 影像系统市场 - 美国市场分析

第 7 章：美国萤光原位杂交 (FISH) 影像系统市场 - 收入和 2030 年预测 - 按产品

第 8 章：美国萤光原位杂交 (FISH) 影像系统市场 - 2030 年收入和预测 -按应用

第 9 章：美国萤光原位杂交 (FISH) 成像系统市场 - 收入和 2030 年预测 - 按最终用户

第 10 章：萤光原位杂交 (FISH) 影像系统市场产业格局

第 11 章：公司简介

第 12 章：附录